MuDr. Zuzana Stejfova

The Revmatologicka ambulance at MuDr. Zuzana Stejfova is conducting research on psoriatic arthritis, an immune system disease. The trial evaluates the efficacy of guselkumab in reducing disease activity.

• Assess reduction in joint swelling and skin lesions
• Monitor patient‑reported pain and functional improvement

This work aims to expand treatment options for patients with active disease and supports the site’s commitment to advancing rheumatology care.

At the same Prague clinic, investigators are comparing baricitinib with standard TNF inhibitors to understand safety concerning Venous Thromboembolism. The focus is on improving therapeutic decision‑making for rheumatoid arthritis.

• Evaluate incidence of VTE events across treatment groups
• Assess overall disease control and quality of life

Findings will help refine risk‑benefit assessments for biologic and targeted synthetic therapies in immune‑mediated arthritis.